WebNov 5, 2024 · Brief Summary: This is a multicenter, randomized, open-label, active comparator-controlled phase Ⅲ trial to compare efficacy and safety of Goserelin Acetate Sustained-Release Microspheres for Injection (LY01005) and ZOLADEX® in patients with breast cancer. Detailed Description: WebSep 25, 2024 · ZOLADEX® was administered as 3 Subcutaneous (SC) injections, 28 days apart. As concomitant medications, Casodex® (50 mg/day) was orally administered during the whole study period. Other Name: goserelin acetate implant 3.6 mg
Home Zoladex® (goserelin implant)
WebDec 1, 2024 · Brief Summary: This is a randomized, open-label and parallel phase I study to compare pharmacokinetics (PK), pharmacodynamics (PD) and safety of goserelin acetate sustained-release microspheres for injection (LY01005) and ZOLADEX® following multiple administration in patients with prostate cancer. Detailed Description: WebLY01005 is an investigational new drug product of goserelin acetate which is formulated as extended-release microspheres for intramuscular injection. To support the proposed clinical trials and marketing application of LY01005, pharmacodynamics, pharmacokinetics and toxicity studies were performed in rats. teamo wine bar
Zoladex (goserelin): Side effects, uses, alternatives, and …
WebGoserelin 3.6 mg subcutaneously at least 1 week before the first cycle of chemotherapy for breast cancer was continued 4-weekly, the last injection being given before the last cycle of chemotherapy in 30 women with breast cancer (9c). Patients with hormone receptor-positive tumors also received tamoxifen at the end of chemotherapy and restarted ... WebJan 13, 2024 · goserelin acetate Company: AstraZeneca UK Limited See contact details ATC code: L02AE03 About Medicine Prescription only medicine Healthcare Professionals (SmPC) Patient Leaflet (PIL) Product Information This information is for use by healthcare professionals Last updated on emc: 13 Jan 2024 Quick Links WebMar 27, 2024 · Goserelin Acetate is a synthetic nonapeptide analog of the hypothalmic decapeptide, gonadorelin. It is obtained by chemical synthesis and is available as an acetate salt. It ... Injection volume: 10 μL System suitability Samples: Standard solution, System suitability solution 1, te amo willy garcia letra